期刊文献+

脑深部电极监测抗癫药物对脑深部核团脑电图的影响 被引量:2

下载PDF
导出
摘要 目的应用脑深部电极监测方法评价抗癫药物对脑深部核团脑电图的影响。方法对3例顽固性癫病人行脑深部电极植入,服用左乙拉西坦后进行持续脑电图监测。应用脑电图定量分析服用药物后的脑电功率变化。结果左乙拉西坦对脑深部脑电图有明显抑制作用,对起源灶的抑制作用更明显,服用药物后1~3h即表现出下降趋势,而在停药后存在反跳现象。结论用脑深部电极监测方法可直接监测抗癫药物对脑深部脑电图的影响,同时应用脑电功率定量检查方法可评价抗癫药物的作用。
出处 《中国微侵袭神经外科杂志》 CAS 北大核心 2009年第6期260-261,共2页 Chinese Journal of Minimally Invasive Neurosurgery
  • 相关文献

参考文献5

二级参考文献62

  • 1杨藻宸.医用药理学(第3版)[M].北京:人民卫生出版社,1993.76.
  • 2Herrmann WM,lrrgang U. An absolute must in clinieopharmacological research: pharmaco- electroencephalography, its possibilities and limitation[J]. Pharmaco-- psychiatria, 1983,16:134.
  • 3Sannita WG, ottonello D, perria B, Rosadini G, Timitilli C.Topographic approaches in human quantitative pharmaco--elect roencephalography[J]. Neuropsyehobiology, 1983,9 (1) : 66-72.
  • 4Logar C0Walzl B. EEG mapping--a new way of monitoring in epilepsy[J]. Eur Neurol, 1994,34 (Suppl 1) : 24 - 28.
  • 5Huang ZC.Shen DL. Studies on quantitative beta activity in EEG background changes produced by intravenous diazepam in epilepsy[J]. Clin Electroencephalogr, 1997,28(3) : 172- 178.
  • 6Wang L, Wang XD. Pharmacokinetie and pharmaeodynamic effects of clonazepam in children with epilepsy treated with valproate:a preliminary study[J]. Ther Drug Monit, 2002, 24(4):532-536.
  • 7Sannita WG, Gervasio L. Quantitative EEG effects and plasma concentration of sodium valproate., acute and long-- term administration to epileptic patients[J]. Neuropsychobiology,1989,22(4):231-235.
  • 8Wu X, Xiao CH. Quantitative pharmaco--EEG of sustained release valproate in epileptics[J]. Clin Electroencephalogr,1997,28(2) :117-120.
  • 9Zenkov LR. Clinical importance of EEG changes during the treatment of epilepsy with valproate (depakene chrono)[J]. Zh Nevrol Psikhiatr 1m S S Korsakova, 2002,102(3) : 20 -26.
  • 10Herkes GK, Lagerlund TD. Effects of antiepileptic drug treatment on the background frequency of EEGs in epileptic patients[J]. J Clin Neurophysiol, 1993,10(2) :210-216.

共引文献49

同被引文献26

  • 1Goldenberg M. Overview of drugs used for epilepsy and seizures : Etiology diagnosis, and treatment [ J 1. PT,2010,35 ( 7 ) : 392 - 415.
  • 2Ramatani G, Ikonomidou C, Walter B, et al. Levetiracetam : Safty and ef- ficacy in neonatal seizures[ J]. Eur J Paediatr Neuro1,2011,15 ( 1 ) : 1 - 7.
  • 3Kaminski RM, Matagne A, Patsalos PN, et al. Benefit of combination therapy in epilepsy : A review of the preclinieal evidence with levetiraee- tam [ J ]. Epilepsia,2009,50 (3) : 387 - 397.
  • 4Vliet EA, Aronica E, Redeker S, et al. Decreased expression of synaptic vesicle protein 2A,the binding site for levetiracetam, during epileptoge- nesis and chronic epilepsy [ J ]. Epilepsia,2009,50 ( 3 ) :422 - 433.
  • 5Rafal MK, Michel G, Karine L,et al. Proepileptie phenotype of SV2A- deficient mice is associated with reduced anticonvulsant efficacy of le,m- tiracetam [ J]. Epilepsia ,2009,50(7 ) : 1729 - 1740.
  • 6Verrotti A, D'Adamo E, Parisi P, et al. Levetiracetam in childhood epi- lepsy [ J ]. Pediatr Drugs,2010,12 ( 3 ) : 177 - 186.
  • 7Lim DA, Tarapore P, Chang E, et al. Safety and feasibility of switching from phenytoin to levetiracetam monotherapy for glioma - related sei- zure control following craniotomy: A randomized phase 2 pilot study [ J]. J Neuroonco1,2009,93 ( 3 ) :349 - 354.
  • 8Ulloa CM ,Towfigh A, Safdieh J. Review of levetiracetam, with a focus on the extended release formulation, as adjuvant therapy in controllingpartial - onset seizures [ J ]. Neuropsychiatr Dis Treat, 2009,5 : 467 - 476.
  • 9Schulze - Bonhage A. Epilepsies and their medical treatment [ J ]. Med Monatsschr Pharm ,2010,33 (6) :207 - 214.
  • 10Wu T, Chen CC, Chen TC, et al. Clinical efficacy and cognitive and neuropsychological effects of levetiracetam in epilepsy : An open - label multicenter study [ J ]. Epilepsy Behav,2009,16 (3) :468 - 474.

引证文献2

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部